Skip to main content
Top
Published in: Journal of Endocrinological Investigation 10/2015

01-10-2015 | Original Article

The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy

Authors: X.-P. Liao, H.-W. Zhu, F. Zeng, Z.-H. Tang

Published in: Journal of Endocrinological Investigation | Issue 10/2015

Login to get access

Abstract

Background

The purpose of this study was to evaluate associations among hypertension (HTN) and uric acid (UA) with cardiovascular autonomic neuropathy (CAN), and to estimate the extent to which synergistic effects of HTN and UA affect the outcome in a Chinese population.

Method

We conducted a large-scale, population-based study to analyze the association and interaction of the two factors for CAN in a sample of 2092 Chinese people. Univariate and multiple linear regression (MLR) analysis were employed to detect these relationships. Interaction on an additive scale can be calculated by using the relative excess risk due to interaction (RERI), the proportion attributable to interaction (AP), and the synergy index (S).

Result

After adjusting for confounding factors, MLR showed that HTN was independently associated with CAN (P < 0.001). A significant interaction effect of UA and HTN on CAN was detected (P = 0.035; RETI = 1.483, 95 % CI 0.415–2.551; AP = 0.360, 95 % CI −0.043 to 0.76 and S = 1.908, 95 % CI 0.152–3.66).

Conclusion

Our findings suggest that HTN is independently and significantly associated with CAN and offer evidence to support the hypothesis that HTN and UA have interaction effects to influence the progression of CAN.
Literature
1.
go back to reference Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223CrossRefPubMed Kearney PM, Whelton M, Reynolds K, Muntner P, Whelton PK et al (2005) Global burden of hypertension: analysis of worldwide data. Lancet 365:217–223CrossRefPubMed
2.
go back to reference Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913CrossRefPubMed Lewington S, Clarke R, Qizilbash N, Peto R, Collins R (2002) Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet 360:1903–1913CrossRefPubMed
3.
go back to reference Guirguis-Blake J (2013) Pharmacotherapy for mild hypertension. Am Fam Phys 88:21 Guirguis-Blake J (2013) Pharmacotherapy for mild hypertension. Am Fam Phys 88:21
4.
go back to reference Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G et al (2012) Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 22:442–448CrossRefPubMed Baldasseroni S, Urso R, Maggioni AP, Orso F, Fabbri G et al (2012) Prognostic significance of serum uric acid in outpatients with chronic heart failure is complex and related to body mass index: data from the IN-CHF Registry. Nutr Metab Cardiovasc Dis 22:442–448CrossRefPubMed
5.
go back to reference Hazari MA, Khan RT, Reddy BR, Hassan MA (2012) Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences 17:173–175PubMed Hazari MA, Khan RT, Reddy BR, Hassan MA (2012) Cardiovascular autonomic dysfunction in type 2 diabetes mellitus and essential hypertension in a South Indian population. Neurosciences 17:173–175PubMed
6.
go back to reference Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; Toronto Consensus Panel on Diabetic Neuropathy (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27(7):639–653CrossRefPubMed Spallone V, Ziegler D, Freeman R, Bernardi L, Frontoni S, Pop-Busui R, Stevens M, Kempler P, Hilsted J, Tesfaye S, Low P, Valensi P; Toronto Consensus Panel on Diabetic Neuropathy (2011) Cardiovascular autonomic neuropathy in diabetes: clinical impact, assessment, diagnosis, and management. Diabetes Metab Res Rev 27(7):639–653CrossRefPubMed
7.
go back to reference Garruti G, Giampetruzzi F, Vita MG, Pellegrini F, Lagioia P et al (2012) Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res 2012:615835CrossRefPubMedPubMedCentral Garruti G, Giampetruzzi F, Vita MG, Pellegrini F, Lagioia P et al (2012) Links between metabolic syndrome and cardiovascular autonomic dysfunction. Exp Diabetes Res 2012:615835CrossRefPubMedPubMedCentral
8.
go back to reference Iodice V, Low DA, Vichayanrat E, Mathias CJ (2011) Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci 310:133–138CrossRefPubMed Iodice V, Low DA, Vichayanrat E, Mathias CJ (2011) Cardiovascular autonomic dysfunction in MSA and Parkinson’s disease: similarities and differences. J Neurol Sci 310:133–138CrossRefPubMed
9.
go back to reference Pafili K, Katsiki N, Mikhailidis DP, Papanas N (2014) Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy. Acta Diabetol 51:893–894CrossRefPubMed Pafili K, Katsiki N, Mikhailidis DP, Papanas N (2014) Serum uric acid as a predictor of vascular complications in diabetes: an additional case for neuropathy. Acta Diabetol 51:893–894CrossRefPubMed
10.
go back to reference Papanas N, Katsiki N, Papatheodorou K, Demetriou M, Papazoglou D et al (2011) Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62:291–295CrossRefPubMed Papanas N, Katsiki N, Papatheodorou K, Demetriou M, Papazoglou D et al (2011) Peripheral neuropathy is associated with increased serum levels of uric acid in type 2 diabetes mellitus. Angiology 62:291–295CrossRefPubMed
11.
go back to reference Erden M, Kocaman SA, Poyraz F, Topal S, Sahinarslan A et al (2011) Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals. Turk Kardiyol Dern Ars: Turk Kardiyoloji Derneginin yayin organidir 39:531–539CrossRef Erden M, Kocaman SA, Poyraz F, Topal S, Sahinarslan A et al (2011) Incremental effects of serum uric acid levels, autonomic dysfunction, and low-grade inflammation on nocturnal blood pressure in untreated hypertensive patients and normotensive individuals. Turk Kardiyol Dern Ars: Turk Kardiyoloji Derneginin yayin organidir 39:531–539CrossRef
12.
go back to reference Lu Y, Tang ZH, Zeng F, Li Y, Zhou L (2013) The association and predictive value analysis of metabolic syndrome combined with resting heart rate on cardiovascular autonomic neuropathy in the general Chinese population. Diabetol Metab Synd 5:73CrossRef Lu Y, Tang ZH, Zeng F, Li Y, Zhou L (2013) The association and predictive value analysis of metabolic syndrome combined with resting heart rate on cardiovascular autonomic neuropathy in the general Chinese population. Diabetol Metab Synd 5:73CrossRef
13.
go back to reference Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW et al (2002) Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med 42:29–37CrossRefPubMed Schabath MB, Spitz MR, Delclos GL, Gunn GB, Whitehead LW et al (2002) Association between asbestos exposure, cigarette smoking, myeloperoxidase (MPO) genotypes, and lung cancer risk. Am J Ind Med 42:29–37CrossRefPubMed
14.
go back to reference Assmann SF, Hosmer DW, Lemeshow S, Mundt KA (1996) Confidence intervals for measures of interaction. Epidemiology 7:286–290CrossRefPubMed Assmann SF, Hosmer DW, Lemeshow S, Mundt KA (1996) Confidence intervals for measures of interaction. Epidemiology 7:286–290CrossRefPubMed
15.
go back to reference Assoumou HG, Pichot V, Barthelemy JC, Dauphinot V, Celle S et al (2010) Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study. Rejuvenation Res 13:653–663CrossRefPubMed Assoumou HG, Pichot V, Barthelemy JC, Dauphinot V, Celle S et al (2010) Metabolic syndrome and short-term and long-term heart rate variability in elderly free of clinical cardiovascular disease: the PROOF study. Rejuvenation Res 13:653–663CrossRefPubMed
16.
go back to reference Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed Lakka HM, Laaksonen DE, Lakka TA, Niskanen LK, Kumpusalo E et al (2002) The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA 288:2709–2716CrossRefPubMed
17.
go back to reference Tahrani AA, Dubb K, Raymond NT, Begum S, Altaf QA et al (2014) Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia 57:1249–1256CrossRefPubMed Tahrani AA, Dubb K, Raymond NT, Begum S, Altaf QA et al (2014) Cardiac autonomic neuropathy predicts renal function decline in patients with type 2 diabetes: a cohort study. Diabetologia 57:1249–1256CrossRefPubMed
18.
go back to reference Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551–556CrossRefPubMed Grundy SM, Hansen B, Smith SC Jr, Cleeman JI, Kahn RA (2004) Clinical management of metabolic syndrome: report of the American Heart Association/National Heart, Lung, and Blood Institute/American Diabetes Association conference on scientific issues related to management. Circulation 109:551–556CrossRefPubMed
19.
go back to reference Zeng F, Tang ZH, Li Z, Yu X, Zhou L (2014) Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest 37(4):385–391CrossRefPubMed Zeng F, Tang ZH, Li Z, Yu X, Zhou L (2014) Normative reference of short-term heart rate variability and estimation of cardiovascular autonomic neuropathy prevalence in Chinese people. J Endocrinol Invest 37(4):385–391CrossRefPubMed
20.
go back to reference Tang ZH, Zeng F, Yu X, Zhou L (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard. Int J Cardiol 171:e78–e80CrossRefPubMed Tang ZH, Zeng F, Yu X, Zhou L (2014) Bayesian estimation of cardiovascular autonomic neuropathy diagnostic test based on baroreflex sensitivity in the absence of a gold standard. Int J Cardiol 171:e78–e80CrossRefPubMed
21.
go back to reference Bian RW, Lou QL, Gu LB, Kong AP, So WY et al (2011) Delayed gastric emptying is related to cardiovascular autonomic neuropathy in Chinese patients with type 2 diabetes. Acta Gastroenterol Belg 74:28–33PubMed Bian RW, Lou QL, Gu LB, Kong AP, So WY et al (2011) Delayed gastric emptying is related to cardiovascular autonomic neuropathy in Chinese patients with type 2 diabetes. Acta Gastroenterol Belg 74:28–33PubMed
22.
go back to reference Ding W, Zhou L, Bao Y, Yang Y, Lu B et al (2011) Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients. Acta Cardiol 66:465–470PubMed Ding W, Zhou L, Bao Y, Yang Y, Lu B et al (2011) Autonomic nervous function and baroreflex sensitivity in hypertensive diabetic patients. Acta Cardiol 66:465–470PubMed
23.
go back to reference Lucini D, Mela GS, Malliani A, Pagani M (2002) Impairment in cardiac autonomic regulation preceding arterial hypertension in humans: insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation 106:2673–2679CrossRefPubMed Lucini D, Mela GS, Malliani A, Pagani M (2002) Impairment in cardiac autonomic regulation preceding arterial hypertension in humans: insights from spectral analysis of beat-by-beat cardiovascular variability. Circulation 106:2673–2679CrossRefPubMed
24.
go back to reference Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51:803–807CrossRefPubMed Panzer C, Lauer MS, Brieke A, Blackstone E, Hoogwerf B (2002) Association of fasting plasma glucose with heart rate recovery in healthy adults: a population-based study. Diabetes 51:803–807CrossRefPubMed
25.
go back to reference Kiani J, Habibi Z, Tajziehchi A, Moghimbeigi A, Dehghan A et al (2014) Association between serum uric acid level and diabetic peripheral neuropathy (A case control study). Caspian J Intern Med 5:17–21PubMedPubMedCentral Kiani J, Habibi Z, Tajziehchi A, Moghimbeigi A, Dehghan A et al (2014) Association between serum uric acid level and diabetic peripheral neuropathy (A case control study). Caspian J Intern Med 5:17–21PubMedPubMedCentral
26.
go back to reference Lefrandt JD, Smit AJ, Zeebregts CJ, Gans RO, Hoogenberg KH (2010) Autonomic dysfunction in diabetes: a consequence of cardiovascular damage. Curr Diabetes Rev 6:348–358CrossRefPubMed Lefrandt JD, Smit AJ, Zeebregts CJ, Gans RO, Hoogenberg KH (2010) Autonomic dysfunction in diabetes: a consequence of cardiovascular damage. Curr Diabetes Rev 6:348–358CrossRefPubMed
Metadata
Title
The association and interaction analysis of hypertension and uric acid on cardiovascular autonomic neuropathy
Authors
X.-P. Liao
H.-W. Zhu
F. Zeng
Z.-H. Tang
Publication date
01-10-2015
Publisher
Springer International Publishing
Published in
Journal of Endocrinological Investigation / Issue 10/2015
Electronic ISSN: 1720-8386
DOI
https://doi.org/10.1007/s40618-015-0291-x

Other articles of this Issue 10/2015

Journal of Endocrinological Investigation 10/2015 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.